Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 216

1.

Successful prolonged treatment of glecaprevir/pibrentasvir for chronic hepatitis C patient with treatment failure after 8-week therapy: a case report.

Naganuma A, Sato K, Fukuchi T, Namikawa M, Kakizaki S, Uraoka T, Ohnishi H, Okamoto H.

Clin J Gastroenterol. 2019 Aug 2. doi: 10.1007/s12328-019-01029-y. [Epub ahead of print]

PMID:
31376076
2.

A comparison of carbon ion radiotherapy and transarterial chemoembolization treatment outcomes for single hepatocellular carcinoma: a propensity score matching study.

Shiba S, Shibuya K, Katoh H, Kaminuma T, Miyazaki M, Kakizaki S, Shirabe K, Ohno T, Nakano T.

Radiat Oncol. 2019 Aug 2;14(1):137. doi: 10.1186/s13014-019-1347-4.

3.

Ledipasvir and Sofosbuvir for Acute Hepatitis C Virus Monoinfection Associated with a High Risk of Acute Liver Failure.

Hatanaka T, Naganuma A, Tateyama Y, Yoshinari F, Hoshino T, Sato K, Hmwe SS, Aizaki H, Wakita T, Kakizaki S, Uraoka T.

Intern Med. 2019 Oct 15;58(20):2969-2975. doi: 10.2169/internalmedicine.2982-19. Epub 2019 Jun 27.

4.

Sofosbuvir/Ribavirin therapy for patients experiencing failure of ombitasvir/paritaprevir/ritonavir + ribavirin therapy: Two cases report and review of literature.

Sato K, Yamazaki Y, Kobayashi T, Takakusagi S, Horiguchi N, Kakizaki S, Andou M, Matsuda Y, Uraoka T, Ohnishi H, Okamoto H.

World J Clin Cases. 2019 May 6;7(9):1043-1052. doi: 10.12998/wjcc.v7.i9.1043.

5.

Impact of the Prognostic Nutritional Index on the Survival of Japanese Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Retrospective Study.

Hatanaka T, Kakizaki S, Uehara D, Nagashima T, Ueno T, Namikawa M, Saito S, Hosonuma K, Suzuki H, Naganuma A, Takagi H, Sato K, Uraoka T.

Intern Med. 2019 Jul 1;58(13):1835-1844. doi: 10.2169/internalmedicine.1594-18. Epub 2019 Mar 28.

6.

Adenosquamous Carcinoma of the Choledochus.

Uehara D, Takagi H, Hoshino T, Suzuki Y, Takakusagi S, Maruhashi K, Kizawa K, Kosone T, Naganuma A, Hisanaga E, Hirato J, Kakizaki S, Uraoka T.

Case Rep Gastroenterol. 2019 Jan 4;12(3):773-779. doi: 10.1159/000495936. eCollection 2018 Sep-Dec.

7.

Non-invasive prediction of non-alcoholic steatohepatitis in Japanese patients with morbid obesity by artificial intelligence using rule extraction technology.

Uehara D, Hayashi Y, Seki Y, Kakizaki S, Horiguchi N, Tojima H, Yamazaki Y, Sato K, Yasuda K, Yamada M, Uraoka T, Kasama K.

World J Hepatol. 2018 Dec 27;10(12):934-943. doi: 10.4254/wjh.v10.i12.934.

8.

β-Hydroxy-β-methyl Butyrate/L-Arginine/L-Glutamine Supplementation for Preventing Hand-Foot Skin Reaction in Sorafenib for Advanced Hepatocellular Carcinoma.

Naganuma A, Hoshino T, Ohno N, Ogawa Y, Murakami T, Horiguchi S, Uehara D, Suzuki Y, Hatanaka T, Kudo T, Ishihara H, Sato K, Kakizaki S, Takagi H.

In Vivo. 2019 Jan-Feb;33(1):155-161. doi: 10.21873/invivo.11452.

9.

Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients.

Uehara D, Seki Y, Kakizaki S, Horiguchi N, Tojima H, Yamazaki Y, Sato K, Yamada M, Uraoka T, Kasama K.

Obes Surg. 2019 Apr;29(4):1195-1201. doi: 10.1007/s11695-018-03641-2.

PMID:
30542827
10.

Constitutive androstane receptor and pregnane X receptor cooperatively ameliorate DSS-induced colitis.

Uehara D, Tojima H, Kakizaki S, Yamazaki Y, Horiguchi N, Takizawa D, Sato K, Yamada M, Uraoka T.

Dig Liver Dis. 2019 Feb;51(2):226-235. doi: 10.1016/j.dld.2018.10.008. Epub 2018 Oct 22.

PMID:
30442521
11.

SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels.

Suga T, Kikuchi O, Kobayashi M, Matsui S, Yokota-Hashimoto H, Wada E, Kohno D, Sasaki T, Takeuchi K, Kakizaki S, Yamada M, Kitamura T.

Mol Metab. 2019 Jan;19:1-12. doi: 10.1016/j.molmet.2018.10.009. Epub 2018 Oct 27.

12.

A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger.

Shibuya K, Ohno T, Katoh H, Okamoto M, Shiba S, Koyama Y, Kakizaki S, Shirabe K, Nakano T.

Radiother Oncol. 2019 Mar;132:230-235. doi: 10.1016/j.radonc.2018.10.009. Epub 2018 Oct 23.

PMID:
30366726
13.

Evaluation of bone healing following Er:YAG laser ablation in rat calvaria compared with bur drilling.

Ohsugi Y, Aoki A, Mizutani K, Katagiri S, Komaki M, Noda M, Takagi T, Kakizaki S, Meinzer W, Izumi Y.

J Biophotonics. 2019 Mar;12(3):e201800245. doi: 10.1002/jbio.201800245. Epub 2018 Dec 9.

PMID:
30324711
14.

[Is Balloon-Occluded Transcatheter Arterial Chemoembolization Effective in Patients with Hepatocellular Carcinoma That Is Unresponsive to Conventional Transcatheter Arterial Chemoembolization ?]

Hatanaka T, Arai H, Shibasaki M, Tojima H, Takizawa D, Toyoda M, Takayama H, Abe T, Sato K, Kakizaki S.

Gan To Kagaku Ryoho. 2018 Sep;45(9):1291-1296. Japanese.

PMID:
30237370
15.

Intratumoral Hemorrhage of Liver Metastasis from a Rectal Neuroendocrine Tumor.

Hatanaka T, Naganuma A, Saito T, Hoshino T, Kakizaki S, Kumasaka T, Takamoto T, Makuuchi M.

Intern Med. 2019 Jan 15;58(2):217-223. doi: 10.2169/internalmedicine.1140-18. Epub 2018 Sep 12.

16.

Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma.

Hatanaka T, Arai H, Kakizaki S.

World J Hepatol. 2018 Jul 27;10(7):485-495. doi: 10.4254/wjh.v10.i7.485. Review.

17.

Techniques for reducing air bubble intrusion into the left atrium during radiofrequency catheter and cryoballoon ablation procedures: An ex vivo study with a high-resolution camera.

Takami M, Fujiwara R, Kijima Y, Nagoshi R, Kozuki A, Mochizuki Y, Shibata H, Nakano S, Fukuyama Y, Fujimoto D, Kakizaki S, Masuko E, Kurimoto H, Kyo S, Miyata T, Shite J.

Heart Rhythm. 2019 Jan;16(1):128-139. doi: 10.1016/j.hrthm.2018.07.038. Epub 2018 Aug 1.

PMID:
30075279
18.

Sofosbuvir-velpatasvir plus ribavirin in Japanese patients with genotype 1 or 2 hepatitis C who failed direct-acting antivirals.

Izumi N, Takehara T, Chayama K, Yatsuhashi H, Takaguchi K, Ide T, Kurosaki M, Ueno Y, Toyoda H, Kakizaki S, Tanaka Y, Kawakami Y, Enomoto H, Ikeda F, Jiang D, De-Oertel S, McNabb BL, Camus G, Stamm LM, Brainard DM, McHutchison JG, Mochida S, Mizokami M.

Hepatol Int. 2018 Jul;12(4):356-367. doi: 10.1007/s12072-018-9878-6. Epub 2018 Jul 20.

19.

In vitro and clinical evaluation of optical coherence tomography for the detection of subgingival calculus and root cementum.

Tsubokawa M, Aoki A, Kakizaki S, Taniguchi Y, Ejiri K, Mizutani K, Koshy G, Akizuki T, Oda S, Sumi Y, Izumi Y.

J Oral Sci. 2018 Sep 23;60(3):418-427. doi: 10.2334/josnusd.17-0289. Epub 2018 May 24.

20.

Improvement of Proteinuria due to Combination Therapy with Daclatasvir and Asunaprevir in Hepatitis C Virus-associated Renal Disease without Cryoglobulinemia.

Takakusagi S, Sato K, Suzuki Y, Yamazaki Y, Kosone T, Kakizaki S, Kusano M, Takagi H.

Intern Med. 2018 Aug 1;57(15):2189-2195. doi: 10.2169/internalmedicine.9624-17. Epub 2018 Mar 9.

21.

Clinical features and treatment of nonalcoholic fatty liver disease across the Asia Pacific region-the GO ASIA initiative.

Chan WK, Treeprasertsuk S, Imajo K, Nakajima A, Seki Y, Kasama K, Kakizaki S, Fan JG, Song MJ, Yoon SK, Dan YY, Lesmana L, Ho KY, Goh KL, Wong VW.

Aliment Pharmacol Ther. 2018 Mar;47(6):816-825. doi: 10.1111/apt.14506. Epub 2018 Jan 14.

22.

Time dependent transition of the levels of protein-conjugated acrolein (PC-Acro), IL-6 and CRP in plasma during stroke.

Yoshida M, Kato N, Uemura T, Mizoi M, Nakamura M, Saiki R, Hatano K, Sato K, Kakizaki S, Nakamura A, Ishii T, Terao T, Murayama Y, Kashiwagi K, Igarashi K.

eNeurologicalSci. 2017 Mar 30;7:18-24. doi: 10.1016/j.ensci.2017.03.005. eCollection 2017 Jun.

23.

Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma.

Shiba S, Abe T, Shibuya K, Katoh H, Koyama Y, Shimada H, Kakizaki S, Shirabe K, Kuwano H, Ohno T, Nakano T.

BMC Cancer. 2017 Nov 7;17(1):721. doi: 10.1186/s12885-017-3724-4.

24.

Indirect activation of pregnane X receptor in the induction of hepatic CYP3A11 by high-dose rifampicin in mice.

Yamasaki Y, Kobayashi K, Inaba A, Uehara D, Tojima H, Kakizaki S, Chiba K.

Xenobiotica. 2018 Nov;48(11):1098-1105. doi: 10.1080/00498254.2017.1400128. Epub 2017 Nov 23.

PMID:
29095659
25.

Observation and determination of periodontal tissue profile using optical coherence tomography.

Kakizaki S, Aoki A, Tsubokawa M, Lin T, Mizutani K, Koshy G, Sadr A, Oda S, Sumi Y, Izumi Y.

J Periodontal Res. 2018 Apr;53(2):188-199. doi: 10.1111/jre.12506. Epub 2017 Oct 24.

PMID:
29063599
26.

Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin.

Sato K, Naganuma A, Nagashima T, Hoshino T, Uehara D, Arai Y, Horiuchi K, Yuasa K, Takayama H, Arai H, Hatanaka T, Ohyama T, Tahara H, Sohara N, Kobayashi T, Horiguchi N, Yamazaki Y, Kakizaki S, Kusano M, Yamada M, Murase T, Nakamura T.

Hepatol Res. 2018 Feb;48(3):E347-E353. doi: 10.1111/hepr.12971. Epub 2017 Sep 25.

PMID:
28834004
27.

Association between Skeletal Muscle Depletion and Sorafenib Treatment in Male Patients with Hepatocellular Carcinoma: A Retrospective Cohort Study.

Naganuma A, Hoshino T, Suzuki Y, Uehara D, Kudo T, Ishihara H, Sato K, Kakizaki S, Yamada M, Takagi H.

Acta Med Okayama. 2017 Aug;71(4):291-299. doi: 10.18926/AMO/55305.

28.

Enhancement of nose-to-brain delivery of hydrophilic macromolecules with stearate- or polyethylene glycol-modified arginine-rich peptide.

Kanazawa T, Kaneko M, Niide T, Akiyama F, Kakizaki S, Ibaraki H, Shiraishi S, Takashima Y, Suzuki T, Seta Y.

Int J Pharm. 2017 Sep 15;530(1-2):195-200. doi: 10.1016/j.ijpharm.2017.07.077. Epub 2017 Jul 27.

PMID:
28757255
29.

An Autopsy Case of Fulminant Hepatitis in a Patient with Multiple Sclerosis Treated by Interferon-Beta-1a.

Yamazaki Y, Suzuki A, Hirayanagi K, Tsukagoshi Y, Uehara R, Horiguchi K, Ohyama T, Tomaru T, Horiguchi N, Nobusawa S, Ikota H, Sato K, Kakizaki S, Kusano M, Ikeda Y, Yokoo H, Yamada M.

Intern Med. 2017;56(14):1897-1901. doi: 10.2169/internalmedicine.56.7980. Epub 2017 Jul 15.

30.

Spontaneous Hemorrhage of a Spinal Ependymoma in the Filum Terminale Presenting with Acute Cauda Equina Syndrome: Case Report.

Terao T, Kato N, Ishii T, Hatano K, Takeishi H, Kakizaki S, Tani S, Murayama Y.

NMC Case Rep J. 2016 May 16;3(3):91-95. doi: 10.2176/nmccrj.cr.2015-0295. eCollection 2016 Jul.

31.

Factors predicting overall response and overall survival in hepatocellular carcinoma patients undergoing balloon-occluded transcatheter arterial chemoembolization: A retrospective cohort study.

Hatanaka T, Arai H, Shibasaki M, Tojima H, Takizawa D, Toyoda M, Takayama H, Abe T, Sato K, Kakizaki S, Yamada M.

Hepatol Res. 2018 Feb;48(2):165-175. doi: 10.1111/hepr.12912. Epub 2017 Jun 22.

PMID:
28500686
32.

A case of an ablation catheter entrapped in the pulmonary vein during atrial fibrillation ablation requiring open heart surgery for removal.

Fujiwara R, Takami M, Kijima Y, Masano T, Nagoshi R, Kozuki A, Shibata H, Nakano S, Fukuyama Y, Kakizaki S, Fujimoto D, Shite J.

HeartRhythm Case Rep. 2016 Oct 3;3(1):87-89. doi: 10.1016/j.hrcr.2016.09.008. eCollection 2017 Jan. No abstract available.

33.

Isolated Gastric Varices Refractory to Balloon-occluded Retrograde Transvenous Obliteration (BRTO) Successfully Treated by Shunt-occluded Endoscopic Injection Sclerotherapy (SO-EIS): A Case Report and Review of the Literature.

Hatanaka T, Kakizaki S, Suzuki Y, Ueno T, Shimada Y, Takizawa D, Katakai K, Sato K, Kusano M, Yamada M.

Intern Med. 2017;56(9):1041-1048. doi: 10.2169/internalmedicine.56.7761. Epub 2017 May 1. Review.

34.

Spontaneous remission of hepatitis B virus reactivation during direct-acting antiviral agent-based therapy for chronic hepatitis C.

Sato K, Kobayashi T, Yamazaki Y, Takakusagi S, Horiguchi N, Kakizaki S, Kusano M, Yamada M.

Hepatol Res. 2017 Nov;47(12):1346-1353. doi: 10.1111/hepr.12905. Epub 2017 May 24.

PMID:
28422376
35.

[A Case of Drug-induced Hypersensitivity Syndrome due to Trichloroethylene].

Fukuchi T, Takizawa D, Adachi T, Ueno T, Hatanaka T, Shimada Y, Kobayashi H, Kakizaki S, Satou K, Yamada M.

Nihon Naika Gakkai Zasshi. 2017 Mar;106(3):598-604. Japanese. No abstract available.

PMID:
30182704
36.

Autochthonous sporadic acute hepatitis E caused by two distinct subgenotype 3b hepatitis E virus strains with only 90% nucleotide identity.

Yamaguchi Y, Takagi H, Suzuki Y, Maruhashi K, Kosone T, Kakizaki S, Sato K, Yamada M, Nagashima S, Takahashi M, Okamoto H.

Clin J Gastroenterol. 2017 Apr;10(2):168-173. doi: 10.1007/s12328-017-0718-3. Epub 2017 Feb 15.

PMID:
28205112
37.

Combination Therapy with Ombitasvir/Paritaprevir/Ritonavir for Dialysis Patients Infected with Hepatitis C Virus: A Prospective Multi-Institutional Study.

Sato K, Hosonuma K, Yamazaki Y, Kobayashi T, Takakusagi S, Horiguchi N, Kakizaki S, Kusano M, Ohnishi H, Okamoto H, Yamada M.

Tohoku J Exp Med. 2017 Jan;241(1):45-53. doi: 10.1620/tjem.241.45.

38.

[A Case of Transfusion-transmitted Acute Hepatitis E].

Kobayashi T, Sato K, Yamazaki Y, Ohyama T, Horiguchi N, Kakizaki S, Kusano M, Yamada M, Yokohama A, Okamoto H.

Nihon Naika Gakkai Zasshi. 2016 Nov;105(11):2215-20. Japanese. No abstract available.

PMID:
30178983
39.

Early Decreases in α-Fetoprotein and Des-γ-carboxy Prothrombin Predict the Antitumor Effects of Hepatic Transarterial Infusion Chemotherapy with Cisplatin (CDDP) Powder in Patients with Advanced Hepatocellular Carcinoma.

Hatanaka T, Kakizaki S, Shimada Y, Takizawa D, Katakai K, Yamazaki Y, Sato K, Kusano M, Yamada M.

Intern Med. 2016;55(16):2163-71. doi: 10.2169/internalmedicine.55.6688. Epub 2016 Aug 15.

40.

Clinical and virological features of acute hepatitis E in Gunma prefecture, Japan between 2004 and 2015.

Yamazaki Y, Naganuma A, Arai Y, Takeuchi S, Kobayashi T, Takakusagi S, Hatanaka T, Hoshino T, Namikawa M, Hashizume H, Takizawa D, Ohyama T, Suzuki H, Horiguchi N, Takagi H, Sato K, Kakizaki S, Kusano M, Nagashima S, Takahashi M, Okamoto H, Yamada M.

Hepatol Res. 2017 Apr;47(5):435-445. doi: 10.1111/hepr.12765. Epub 2016 Jul 27.

PMID:
27322051
41.

Efficacy and Safety of Endoscopic Gallbladder Stenting for Acute Cholecystitis in Patients with Concomitant Unresectable Cancer.

Hatanaka T, Itoi T, Ijima M, Matsui A, Kurihara E, Okuno N, Kobatake T, Kakizaki S, Yamada M.

Intern Med. 2016;55(11):1411-7. doi: 10.2169/internalmedicine.55.5820. Epub 2016 Jun 1.

42.

Fatal fulminant hepatitis caused by infection with subgenotype A1 hepatitis B virus with C1766T/T1768A core promoter mutations.

Hoshino T, Takagi H, Suzuki Y, Naganuma A, Sato K, Kakizaki S, Nishizawa T, Okamoto H, Yamada M.

Clin J Gastroenterol. 2016 Jun;9(3):160-7. doi: 10.1007/s12328-016-0649-4. Epub 2016 May 10.

PMID:
27165167
43.

A case of idiopathic portal hypertension associated with nodular regenerative hyperplasia-like nodule of the liver and mixed connective tissue disease.

Hayano S, Naganuma A, Okano Y, Suzuki Y, Shiina K, Yoshida H, Hayashi E, Uehara S, Hoshino T, Miyamae N, Kudo T, Ishihara H, Ogawa A, Sato K, Kakizaki S.

Nihon Shokakibyo Gakkai Zasshi. 2016 May;113(5):828-36. doi: 10.11405/nisshoshi.113.828. Japanese.

PMID:
27151480
44.

New endoscopic classification of cascade stomach, a risk factor for reflux esophagitis.

Kusano M, Hosaka H, Yasuoka H, Kawamura O, Kawada A, Kuribayashi S, Shimoyama Y, Mizuide M, Tomizawa T, Ishihara S, Sagawa T, Akiyama J, Sato K, Kakizaki S, Moki F.

J Gastroenterol. 2017 Feb;52(2):211-217. doi: 10.1007/s00535-016-1214-0. Epub 2016 Apr 27.

PMID:
27121685
45.

Combination therapy with daclatasvir and asunaprevir for dialysis patients infected with hepatitis C virus.

Sato K, Yamazaki Y, Ohyama T, Kobayashi T, Horiguchi N, Kakizaki S, Kusano M, Yamada M.

World J Clin Cases. 2016 Mar 16;4(3):88-93. doi: 10.12998/wjcc.v4.i3.88.

46.

Endoscopic treatment for esophageal varices complicated by Isaacs' syndrome involving difficulty with conventional sedation.

Suzuki Y, Yamazaki Y, Hashizume H, Kobayashi T, Ohyama T, Horiguchi N, Sato K, Kakizaki S, Kusano M, Yamada M.

Clin J Gastroenterol. 2016 Feb;9(1):27-31. doi: 10.1007/s12328-016-0626-y. Epub 2016 Feb 10.

PMID:
26862027
47.

Malignant Peripheral Nerve Sheath Tumor of the Liver.

Kakizaki S, Horiguchi N, Otsuka T, Takizawa D, Yamazaki Y, Sato K, Ohno Y, Kusano M, Yamada M.

Intern Med. 2016;55(3):245-9. doi: 10.2169/internalmedicine.55.5456. Epub 2016 Feb 1. Review.

48.

Faecal lactoferrin is a useful biomarker for mucosal healing in patients with ulcerative colitis during granulocyte and monocyte adsorptive apheresis therapy.

Sagawa T, Kakizaki S, Tomizawa T, Nakayama T, Tanaka H, Tojima H, Sato K, Kusano M, Okamura S, Yamada M.

Colorectal Dis. 2016 Jul;18(7):696-702. doi: 10.1111/codi.13258.

PMID:
26748553
49.

Probable case of drug reaction with eosinophilia and systemic symptom syndrome due to combination therapy with daclatasvir and asunaprevir.

Suga T, Sato K, Yamazaki Y, Ohyama T, Horiguchi N, Kakizaki S, Kusano M, Yamada M.

World J Clin Cases. 2015 Dec 16;3(12):1005-10. doi: 10.12998/wjcc.v3.i12.1005.

50.

Hepatic Angiosarcoma with Dyskeratosis Congenita.

Horiguchi N, Kakizaki S, Iizuka K, Hagiwara S, Ohyama T, Yamazaki Y, Shibusawa N, Sato K, Kusano M, Nakazato Y, Yamada M.

Intern Med. 2015;54(22):2867-72. doi: 10.2169/internalmedicine.54.5206. Epub 2015 Nov 15.

Supplemental Content

Loading ...
Support Center